Immuron Limited Gains 42.27%
Tue 21 Jul 20 at 05:33 PM
Immuron Limited (IMRN:NASDAQ) rocketted at $14.81, a gain of 42.3%. On Mon 20 Jul 20, IMRN:NASDAQ touched a New 2-Week High of $10.41. The stock got featured on our News Catalysts scanner on Mon 20 Jul 20 at 06:43 AM in the 'BIOTECH' category. From Mon 06 Jul 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Mon 20 Jul 20 at $19.5 with a volume of 67M+.
About Immuron Limited (IMRN:NASDAQ)
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Top 10 Gainers:
- Midatech Pharma plc (MTP:NASDAQ), 152.94%
- Owens & Minor, Inc. (OMI:NYSE), 81.36%
- Novan, Inc. (NOVN:NASDAQ), 78.26%
- Ocugen, Inc. (OCGN:NASDAQ), 61.25%
- Tellurian Inc. (TELL:NASDAQ), 56.44%
- New Concept Energy, Inc. (GBR:NYSEMKT), 47.01%
- Immuron Limited (IMRN:NASDAQ), 42.27%
- DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ), 41.5%
- New Age Beverages Corporation (NBEV:NASDAQ), 41.38%
- Independence Contract Drilling, Inc. (ICD:NYSE), 34.57%